N-benzylcantharidinamide promoted the degradation of matrix metalloproteinase-9 (MMP-9) mRNA in an antigen R-dependent manner in human hepatocellular carcinoma Hep3B cells. The gene discussed is MMP9; the disease is hepatocellular carcinoma.